Money Talks News on MSN
Pfizer's 2025 COVID vaccine boosts immunity 4x, access severely limited nationwide
Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...
The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...
The Trump administration is expected to announce deals with Eli Lilly and Novo Nordisk to cut prices of some weight loss ...
How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...
Eli Lilly and Novo Nordisk have agreed pricing deals for GLP-1RA brands, a pivotal moment in the obesity treatment market.
CT Insider on MSN
After Electric Boat's Crystal Mall purchase, apartments could follow
A spokesperson in Gov. Ned Lamont's administration did not rule out the state making available a nearly 125-acre tract for ...
Tokyo’s benchmark Nikkei 225 index dropped by 1,284.93 points, or 2.50 percent on Wednesday and other shares in Asia also sank after a retreat on Wall Street spurred by selling of Big Tech shares. The ...
When Britain's children return to school next week as the country eases its third lockdown, six-year-old Daniel Meredith will ...
Pharma’s push into direct-to-patient sales is reshaping the front end of drug distribution, but wholesalers like Cencora, McKesson, and Cardinal Health remain indispensable as the backbone of the ...
Pfizer is working to deal with typical business issues in the drug space, but its attempt at a solution has become very complicated.
The bidding war between Pfizer ( PFE) and Novo Nordisk ( NVO) over obesity drug developer Metsera ( MTSR) finally ended over ...
On Monday, 10 November 2025, the healthcare world was abuzz as two pharmaceutical giants, Pfizer and Novo Nordisk, fiercely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results